StockDuty ← Dashboard Nov 16, 2026 10:30 PM ET
SignalCorporate

Interpace Biosciences GAAP EPS of -$0.26, revenue of $10.4M

Interpace Biosciences GAAP EPS of -$0.26, revenue of $10.4M

Interpace Biosciences GAAP EPS of -$0.26, revenue of $10.4M
Interpace Biosciences GAAP EPS of -$0.26, revenue of $10.4M — impact context not separately stored; see What changed.
Sources